Mechanistic Insight of Probiotics Derived Anticancer Pharmaceuticals: A Road Forward for Cancer Therapeutics

Nutrition and Cancer

Volumn 69, Issue 3, 2017, Pages 375-380

  Kumar, Raman ^a   Dhanda, Suman ^a  

^a KURUKSHETRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; BACTERIAL ENZYME; HEAVY METAL; IMMUNOMODULATING AGENT; PROBIOTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACILLUS; BACILLUS POLYFERMENTICUS; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BREVE; BIOFILM; CANCER CELL LINE; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; COLON CANCER; DRUG EFFICACY; DRUG MECHANISM; ENTEROCOCCUS DURANS; ENZYME ACTIVITY; ENZYME INHIBITION; FUTUROLOGY; GENOTOXICITY; HEAVY METAL REMOVAL; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MALIGNANT NEOPLASM; NONHUMAN; PROPIONIBACTERIUM FREUDENREICHII; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STREPTOCOCCUS THERMOPHILUS; ANIMAL; COLON TUMOR; DISEASE MODEL; DNA DAMAGE; IMMUNE SYSTEM; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA DAMAGE; HUMANS; IMMUNE SYSTEM; METALS, HEAVY; PROBIOTICS;

EID: 85014890987     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2017.1267773     Document Type: Review

References (41)

1. Mohammadi M, :Probiotic and cancer. J Biol Today's World 2, 202–209, 2013.
2. World Cancer Report 2014, World Health Organisation. 2014.
3. Haghshenas B, Nami Y, Abdullah N, Radiah D, Rosli R, et al.:Anticancer impacts of potentially probiotic acetic acid bacteria isolated from traditional dairy microbiota. LWT—Food Sci Technol 60, 690–697, 2015.
4. Biradar YS, Jagatap S, Khandelwal KR, and Singhania SS, :Exploring of antimicrobial activity of Triphala Mashi-an ayurvedic formulation. Evidence-based Complement Altern Med 5, 107–113, 2008.
5. Miranda CL, Stevens JF, Hemlmrich A, Henderson MC, Rodriguez RJ, et al.:Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Human lupulus) in human cancer cell lines. Food Chem Toxicol 37, 271–285, 1999.
6. Daniluk U, :Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment? Clin Exper Oncol 1, 2, 2012.
7. Goldin BR, and Gorbach SL, :Clinical indications for probiotics:an overview. Clin Infect Dis 46, 96–100, 2008.
8. Kim Y, Lee D, Kim D, Cho J, Yang J, et al.:Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by bifidobacterium adolescentis SPM0212. Arch Pharm Res 31, 468–473, 2008.
9. Santosa S, :Probiotics and their potential health claims. Nutr Rev 64, 265–274, 2006.
10. Djouzi Z, Andrieux C, Degivry MC, Bouley C, and Szylit O, :The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. J Nutr 127, 2260–2266, 1997.
11. Stark AA, Essigmann JM, Demain AL, Skopek TR, and Wogan GN, :Aflatoxin B1 mutagenesis, DNA binding and adduct formation in Salmonella typhimurium. Proc Natl Acad Sci USA 76, 1343–1347, 1979.
12. Kumar KS, Sastry N, Polaki H, and Mishra V, :Colon cancer prevention through probiotics:an overview. J Cancer Sci Ther 7(2), 081–092, 2015.
13. Ma EL, Choi YJ, Choi J, Pothoulakis C, Rhee SH, et al.:The anti-cancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Intl J Cancer 127, 780–790, 2010.
14. Hirayama K, and Rafter J, :The role of probiotic bacteria in cancer prevention. Microbes Infect 2, 681–686, 2000.
15. Kumar M, Verma V, Nagpal R, Kumar A, Behare PV, et al.:Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats. Br J Nutr 107, 1006–1016, 2012.
16. Orland A, Refolo MG, Messa C, Amati L, Lavermicocca P, et al.:Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer 64, 1103–1111, 2012.
17. Choi SS, Kim Y, Han KS, You S, Oh S, et al.:Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol 42, 452–458, 2006.
18. Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, et al.:Synbiotics reduce postoperative infectious complications:a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck's Arch Surgery 390, 104–113, 2005.
19. Haghshenas B, Nami Y, Abdullah N, Radiah D, Rosli R, et al.:Anti proliferative effects of Enterococcus strains isolated from fermented dairy products on different cancer cell lines. J Funct Foods 11, 363–374, 2014.
20. Iyer C, Kosters A, Sethi G, Kunnumakkara AB, Aggarwal B, et al.:Probiotic Lactobacillus reuteri promotes TNF-inducedapoptosis in human myeloid leukemia-derived cells by modulation of NF-kB and MAPK signaling. Cell Microbiol 10, 1442–1452, 2008.
21. Nami Y, Abdullah N, Haghshenas B, Radiah D, Rosli R, et al.:Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells. Anaerobe, 28, 29–36, 2014.
22. Ghoneum M, El-Din NKB, Noaman E, and Tolentino T, :Saccharomyces cerevisiae, the Baker's Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice. Cancer Immunol Immunother 57, 581–592, 2008.
23. Rafter J, :The effects of probiotics on colon cancer development. Nutr Res Rev 17, 277–284, 2004.
24. Arimochi H, Kinouchi T, Kataoka K, Kuwahara T, and Ohnishi Y, :Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem Biophys Res Commun 238, 753–757, 1997.
25. Uccello M, Malaguarnera G, Basile F, D'agata V, Malaguarnera M, et al.:Potential role of probiotics on colorectal cancer prevention. BioMed Central Surg 12, S35, 2012.
26. Fotiadis CI, Stoidis CN, Spyropoulos BG, and Zografos ED, :Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J Gastroenterol 14, 6453–6457, 2008.
27. Goldin BR, and Gorbach SL, :Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus:decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst 73, 689–695, 1984.
28. Gabrilovich D, and Pisarev V, :Tumor escape from immune response:mechanisms and targets of activity. Current Drug Targets 4, 525–536, 2003.
29. Matsuzaki T, :Immunomodulation by treatment with Lactobacillus casei strain Shirota. Intl J Food Microbiol 41, 133–140, 1990.
30. Yasui H, Shida K, Matsuzaki T, and Yokokura T, :Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 383–389, 1999.
31. Lee JW, Shin JG, Kim EH, Kang HE, Yim BI, et al.:Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 5, 41–48, 2004.
32. Commane D, Hughes R, Shortt C, and Rowland I, :The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 591, 276–289, 2005.
33. Rowland IR, and Gangolli SD, :Role of gastrointestinal flora in the metabolic and toxicological activities of xenobiotics. In:General and Applied Toxicology, Ballantyne B, Mars TC, and Syverson (eds.), Second ed. London:Macmillan Publishers Ltd., pp. 561–576.
34. Burns AJ, and Rowland IR, :Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat Res 551, 233–243, 2004.
35. Monachese M, Burton JP, and Reid G, :Bioremediation and tolerance of humans to heavy metals through microbial processes:a potential role for probiotics? Appl Environ Microbiol 78, 6397–6404, 2012.
36. Gavrilescu M, :Removal of heavy metals from the environment by biosorption. Engin Life Sci 4, 219–232, 2004.
37. Halttunen T, Salminen S, and Tahvonen R, :Rapid removal of lead and cadmium from water by specific lactic acid bacteria. Intl J Food Microbiol 114, 30–35, 2007.
38. 1-3. Am J Clin Nutr 80, 737–741, 2004.
39. Attri P, Jodha D, Gandhi D, and Dhanda S, :Screening of intracellular, extracellular and membrane bound exopeptidases in Lactic Acid Bacteria (LAB). Milchwissenschaft - Milk Sci Intl 67, 421–424, 2012.
40. Attri P, Khaket TP, Jodha D, Singh J, and Dhanda S, :Biochemical and kinetic characterization of DING from the probiotic Pediococcus acidilactici. Appl Biochem Biotechnol 175, 1092–1110, 2015.
41. Attri P, Jodha D, Gandhi D, Chanalia P, and Dhanda S, :In vitro evaluation of Pediococcus acidilactici NCDC 252 for its probiotics attributes. Intl J Dairy Technol 2015. doi:10.1111/1471-0307.12194.